bioRxiv · 10.1101/2021.04.08.438954
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq
Abstract
We present Beyondcell (https://gitlab.com/bu_cnio/beyondcell/), a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines therapeutic differences among cell populations, and generates a prioritised ranking of the differential sensitivity drugs between chosen conditions to guide drug selection. We performed Beyondcell analysis in four single-cell datasets to validate our score and to demonstrate that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Fustero-Torre, C., Jimenez-Santos, M. J., Garcia-Martin, S., Carretero-Puche, C., Garcia-Jimeno, L., Di Domenico, T., Gomez-Lopez, G., Al-Shahrour, F.. 2021-04-09. Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq. https://doi.org/10.1101/2021.04.08.438954
Cite the original work for its findings. Save a collection to share your selection of sources.